Month: September 2026
-
Yancy Receives 2026 Herbert W. Nickens Award
Clyde W. Yancy, MD, MSc, the Magerstadt Professor and chief of Cardiology in the Department of Medicine and Vice Dean for Health Equity, has been selected as the recipient of the 2026 Herbert W. Nickens Award from the Association of American Medical Colleges.
-
Chen Named Director of Educator Development and Teaching Excellence
Diane Chen, PhD, professor of Psychiatry and Behavioral Sciences, Pediatrics, and Medical Social Sciences, has been named Director of Educator Development and Teaching Excellence at Feinberg.
-
Medical Education Day Explores Future of Learning
Faculty, trainees, students and staff gathered on September 23 for the 16th Annual Medical Education Day, a yearly celebration of teaching excellence, educational innovation and scholarship across the Feinberg community.
-
Investigating How Dopamine Influences Movement
A new Northwestern Medicine study challenges traditional ideas about how dopamine influences movement, according to findings published in Science Advances.
-
Novel AI Tool Rapidly Measures Colonoscopy Quality
Northwestern scientists have developed an AI tool that rapidly and successfully measures colonoscopy quality by reviewing footage of the procedure.
-
Imaging Agent May Improve Diagnoses for Rare Heart Disease
A PET/CT radiotracer demonstrated high sensitivity and specificity for detecting cardiac amyloidosis and could provide diagnostic clarity when standard imaging tests do not provide definitive results, according to a recent clinical trial published in JAMA.
-
RNA Therapy May Help Preserve Muscle During GLP-1 Weight Loss
A new Northwestern University study offers a potential solution to muscle loss during GLP-1 therapy: an experimental RNA therapy that induces the body to burn calories, enhancing the benefits of the weight-loss treatment.
-
Genetic Toolkit May Improve Study of Gut Bacteria’s Role in Disease
A novel genetic toolkit may improve the study of how Clostridia bacteria in the gut contribute to disease and reveal new molecular mechanisms that may serve as effective therapeutic targets, as detailed in a recent study published in Nature Biotechnology.
-
Experimental Drug Shows Potential for Hard-to-Treat Heart Disease
An experimental drug has been shown to improve symptoms, exercise capacity and heart failure status in patients with an inherited heart disease, according to a pair of newly published studies.
-
Investigating the Role of Lymphatic Vessels in Heart Growth and Repair
A Northwestern Medicine study has uncovered a previously unknown signaling system that helps regulate heart growth during development, according to the study published in the journal Genes and Development.
